Technetium 99m ethylcysteinate dimer single-photon emission computed tomography (SPECT) during intellectual stress test in children and adolescents with pure versus comorbid attention-deficit hyperactivity disorder (ADHD)

Journal of Child Neurology

Volumn 19, Issue 2, 2004, Pages 91-96

  Lorberboym, Mordechai ^a   Watemberg, Nathan ^c   Nissenkorn, Andreea ^a   Nir, Batia ^a   Lerman Sagie, Tally ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BASAL GANGLION; BRAIN PERFUSION; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EXERCISE TEST; FEMALE; FRONTAL CORTEX; FRONTAL LOBE; HUMAN; INTELLIGENCE TEST; LEARNING DISORDER; MALE; MOOD DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; REGIONAL PERFUSION; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TASK PERFORMANCE; TEMPORAL LOBE;

EID: 1842538124     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738040190020201     Document Type: Article

References (40)

1. Brown RT, Freeman WS, Perrin JM, et al: Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 2001;107:E43.
2. Wolraich ML, Hannah JN, Baumgaertel A, Feurer ID: Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr 1998;119:162-168.
3. Rhee SH, Waldman ID, Hay DA, Levy F: Sex differences in genetic and environmental influences on DSM-III-R attention-deficit/hyperactivity disorder. J Abnorm Psychol 1999;108:24-41.
4. Newcorn JH, Halperin JM, Jensen PS, et al: Symptom profiles in children with ADHD: Effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry 2001;40:137-146.
5. Geller DA, Biederman J, Faraone SV, et al: Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: Fact or artifact? J Am Acad Child Adolesc Psychiatry 2002;41:52-58.
6. Seidman LJ, Biederman J, Monuteaux MC, et al: Learning disabilities and executive dysfunction in boys with attention-deficit/hyperactivity disorder. Neuropsychology 2001;15:544-556.
7. Wolraich ML, Lindgren S, Stromquist A, et al: Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics 1990;86:95-101.
8. Levy F, Barr C, Sunohara G: Directions of aetiologic research on attention deficit hyperactivity disorder. Aust N Z J Psychiatry 1998;32:97-103.
9. Pincus JH, GlIser GH: The syndrome of "minimal brain damage" In childhood. N Engl J Med 1966;275:27-35.
10. Sagvolden T, Sergeant JA: Attention deficit/hyperactivity disorder - From brain dysfunctions to behaviour. Behav Brain Res 1998; 94:1-10.
11. Castellanos FX, Giedd JN, Marsh WL, et al: Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996;53:607-616.
12. Mann CA, Lubar JF, Zimmerman AW, et al: Quantitative analysis of EEG in boys with attention-deficit-hyperactivity disorder: Controlled study with clinical implications. Pediatr Neurol 1992;8:30-36.
13. Zametkin AJ, Liebenauer LL, Fitzgerald GA, et al: Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993;150:333-340.
14. Benson DF: The role of frontal dysfunction in attention deficit hyperactivity disorder. J Child Neurol 1991;6 (Suppl 6):S9-S12.
15. Forbes GB: Clinical utility of the Test of Variables of Attention (TOVA) in the diagnosis of attention-deficit/hyperactivity disorder. J Clin Psychol 1998;54:461-476.
16. Greenberg LM, Waldman ID: Developmental normative data on the test of variables of attention (T.O.V.A.). J Child Psychol Psychiatry 1993;34:1019-1030.
17. Catafau AM, Lomena FJ, Pavia J, et al: Regional cerebral blood flow pattern in normal young and aged volunteers: A 99mTc-HMPAO SPET study. Eur J Nucl Med 1996;23:1329-1337.
18. Filipek P, Semrud Clikeman M, Steingard RJ, et al: Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997;48:589-601.
19. Baumgardner TL, Singer HS, Denckla MB, et al: Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder. Neurology 1996;47:477-482.
20. O'Tuama LA, Treves ST: Brain single-photon emission computed tomography for behavior disorders in children. Semin Nucl Med 1993;23:255-264.
21. Lou HC, Henriksen L, Bruhn P: Focal cerebral dysfunction in developmental learning disabilities. Lancet 1990;335:8-11.
22. Sieg KG, Gaffney GR, Preston DF, Hellings JA: SPECT brain imaging abnormalities in attention deficit hyperactivity disorder. Clin Nucl Med 1995;20:55-60.
23. Lou HC, Henriksen L, Bruhn P: Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol 1984;41:825-829.
24. Zametkin AJ, Nordahl TE, Gross M, et al: Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990;323:1361-1366.
25. Ernst M, Liebenauer LL, King AC, et al: Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry 1994;33:858-868.
26. Matochik JA, Liebenauer LL, King AC, et al: Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment. Am J Psychiatry 1994; 151:658-664.
27. Niedermeyer E: Frontal lobe functions and dysfunctions. Clin Electroencephalogr 1998;29:79-90.
28. Blumer D, Heilbronn M, Himmelhoch J: Indications for carbamazepine in mental illness: Atypical psychiatric disorder or temporal lobe syndrome? Compr Psychiatry 1988;29:108-122.
29. Devinsky O, Bear D: Varieties of aggressive behavior in temporal lobe epilepsy. Am J Psychiatry 1984;141:651-656.
30. Amen DG, Carmichael BD. High-resolution brain SPECT imaging in ADHD. Ann Clin Psychiatry 1997;19:81-86.
31. Pliszka SR, Liotti M, Woldorff MG: Inhibitory control in children with attention-deficit/hyperactivity disorder: Event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. Biol Psychiatry 2000;48:238-246.
32. Rubia K, Overmeyer S, Taylor E, et al: Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI. Am J Psychiatry 1999;156:891-896.
33. Oades RD: Frontal, temporal and lateralized brain function in children with attention-deficit hyperactivity disorder: A psychophysiological and neuropsychological viewpoint on development. Behav Brain Res 1998;94:83-95.
34. Shue KL, Douglas VI: Attention deficit hyperactivity disorder and the frontal lobe syndrome. Brain Cogn 1992;20:104-124.
35. Volavka J, Martell D, Convit A: Psychobiology of the violent offender. J Forens Sci 1992;37:237-251.
36. Johnston C, Pelham WE, Hoza J, Sturges J: Psychostimulant rebound in attention deficit disordered boys. J Am Acad Child Adolesc Psychiatry 1988;27:806-810.
37. Nasrallah HA, Loney J, Olson SC, et al: Cortical atrophy in young adults with a history of hyperactivity in childhood. Psychiatry Res 1986;17:241-246.
38. Xiberas X, Martinot JL, Mallet L, et al: Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. Br J Psychiatry 2001;179:503-508.
39. Schreier HA: Risperidone for young children with mood disorders and aggressive behavior. J Child Adolesc Psychopharmacol 1998;8:49-59.
40. Kewley GD: Risperidone in comorbid ADHD and ODD/CD. J Am Acad Child Adolesc Psychiatry 1999;38:1327-1328.